Sustained healthcare systems need sustainable pharma business models

COVID-19 demonstrated the importance of robust supply chains and the dangers of an over reliance on overseas manufacturing. But can the Pharmaceutical Strategy for Europe help to redress the balance?

Only sustainable, robust supply chains and business models will allow innovation to flourish, secure access to medicines, and minimise the industry’s impact on the environment.

Read the source article at pharmaphorum.com
2021-10-26 12:56:33